导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -18.94% | 4303/4773 |
| 近一周 | -4.91% | 5162/5462 |
| 近一月 | -2.89% | 1453/5421 |
| 近一季 | -9.82% | 3341/5209 |
| 近半年 | -24.96% | 4708/4920 |
| 近一年 | -18.44% | 3867/4366 |
| 近两年 | 9.97% | 2807/2954 |
| 近三年 | -29.07% | 2206/2253 |
| 成立以来 | 3.15% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.88% 1418/4961 |
-14.35% 4567/5312 |
- - |
- - |
| 2025 | 7.23% 2932/4813 |
0.49% 1833/3635 |
-3.22% 3418/4076 |
8.12% 3418/4524 |
1.98% 1123/4813 |
| 2024 | -4.22% 2236/3463 |
-6.28% 2038/2808 |
-6.60% 1984/3014 |
13.35% 2188/3129 |
-3.46% 2351/3463 |
| 2023 | -21.13% 1894/2656 |
1.37% 1580/2280 |
-11.28% 2156/2385 |
2.08% 258/2515 |
-14.09% 2479/2655 |
| 2022 | -22.85% 1094/2207 |
-7.18% 237/1919 |
2.84% 1248/2016 |
-21.61% 1907/2113 |
3.10% 770/2208 |
| 2021 | 10.25% 437/1822 |
8.69% 60/1255 |
-0.85% 1152/1330 |
-2.61% 585/1466 |
5.05% 307/1822 |
| 2020 | 22.46% 670/1250 |
-0.49% 188/1028 |
5.28% 887/1067 |
16.06% 173/1164 |
0.72% 1052/1184 |
| 2019 | 52.44% 90/1092 |
33.34% 137/739 |
-0.62% 270/788 |
-4.49% 773/850 |
20.44% 3/918 |
| 2018 | -26.00% 368/834 |
- - |
-18.06% 594/631 |
1.17% 140/660 |
-11.65% 334/682 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 广发中证全指建筑材料指数C VS. 长安沪深300非周期A(740101) |